Targeted chemotherapy or placebo to treat patient with lung cancer that has been completely removed by surgery
Can targeted chemotherapy (Erlotinib) stop the growth of tumor cells by blocking some of the enzymes needed for cell growth?
ALK Gene Rearrangement EGFR Exon 19 Deletion Mutation EGFR NP_005219.2:p.L858R Stage IB Lung Non-Small Cell Carcinoma AJCC v7 Stage II Lung Non-Small Cell Cancer AJCC v7 Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Carcinoma Carcinoma, Non-Small-Cell Lung Erlotinib Hydrochloride Clinical Observation Laboratory Biomarker Analysis
Lead Scientists at UC Health
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- Jonathan W. Riess (ucdavis)
Assistant Professor, Hematology and Oncology. Authored (or co-authored) 45 research publications
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Phase 3
- Study Type
- Last Updated